Table 6.
Rifaximin and lactulose administration by analysis group 24–48 h post-intubation
| Altered Mental Status/HE | Respiratory Failure/Cardiovascular Instability | Procedure | All Patients | |
|---|---|---|---|---|
|
| ||||
| n | 70 | 150 | 94 | 314 |
| 24-h prior to intubation | ||||
| Patients given Rifaximin (%) | 40 (57.1) | 63 (42.0) | 24 (25.5) | 127 (40.4) |
| Lactulose enema received (%) | 3 (4.3) | 4 (4.7) | 14 (14.9) | 24 (7.6) |
| Patients given Lactulose PO1 (%) | 49 (70.0) | 87 (58.0) | 45 (47.9) | 181 (57.6) |
| Lactulose PO1 median number of doses2,3 [IQR] | 8 [6, 10] | 6 [3, 8] | 4 [2, 6] | 6 [3, 8] |
1
Oral administration
2
Calculated based only on patients that received the treatment
3
1 dose Lactulose: 10 g